Raynaud's phenomenon and acrocyanosis – Related resources
08.02.2012 • Sonuncu dəyişiklik 24.01.2014
This article is created and updated by the EBMG Editorial Team
Cochrane reviews
- Prazosin may be modestly effective in the treatment of Raynaud's phenomenon secondary to scleroderma .
- There is insufficient evidence of the effect of any drugs with vasodilator effects (excluding calcium channel blockers which were not considered in this review) on primary Raynaud's phenomenon .
Literature
- Herrick AL. Management of Raynaud's phenomenon and digital ischemia. Curr Rheumatol Rep 2013;15(1):303.
- Goundry B, Bell L, Langtree M et al. Diagnosis and management of Raynaud's phenomenon. BMJ 2012;344:e289.
- Baumhäkel M, Böhm M. Recent achievements in the management of Raynaud's phenomenon. Vasc Health Risk Manag 2010;6():207-14.